Systemic versus intracoronary thrombolysis in acute myocardial infarction

Giornale Italiano Di Cardiologia
|January 1, 1983
PubMed

Insights

Intravenous streptokinase (SK) infusion achieved a 58% recanalization rate for occluded coronary arteries, lower than intracoronary SK. Early treatment within 3 hours preserved heart muscle by restoring blood flow.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Thrombolytic Therapy

Background:

  • Complete coronary artery occlusion requires prompt restoration of blood flow to prevent myocardial damage.
  • Thrombolytic therapy, using agents like streptokinase, is a key treatment strategy for acute myocardial infarction.
  • Comparing intravenous and intracoronary administration routes is crucial for optimizing treatment efficacy.

Purpose of the Study:

  • To review and compare the recanalization rates and thrombus lysis times of intravenous versus intracoronary streptokinase (SK) for occluded coronary arteries.
  • To evaluate the utility of serum enzyme curves (MB-CK) in assessing coronary blood flow restoration.
  • To determine the impact of early reperfusion on preserving jeopardized myocardium in acute myocardial infarction.

Main Methods:

  • Review of published reports on streptokinase infusion for coronary artery occlusion.
  • Analysis of recanalization rates and thrombus lysis times for both intravenous and intracoronary SK.
  • Assessment of serial serum enzyme curves (MB-CK) to estimate coronary blood flow.
  • Angiographic evaluation of left ventricular wall motion abnormalities in relation to treatment timing.

Main Results:

  • Intravenous SK infusion achieved a 58% recanalization rate, compared to 77% for intracoronary SK.
  • Thrombus lysis time was longer with intravenous SK compared to intracoronary administration.
  • Thrombus age significantly influences lysis time.
  • Early treatment (within 3 hours) with restored coronary blood flow preserved jeopardized myocardium, as indicated by improved left ventricular wall motion.

Conclusions:

  • Intracoronary streptokinase demonstrates a higher recanalization rate than intravenous infusion for occluded coronary arteries.
  • Early restoration of coronary blood flow, particularly within 3 hours of acute myocardial infarction, is critical for myocardial salvage.
  • MB-CK enzyme curves provide valuable insights into the effectiveness of reperfusion therapy.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...